HomeAI · summaries
Storia in 3 fonti
New study supports testing of Merck’s Ebola vaccine in DRC outbreak
New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Health workers may get experimental Ebola vaccine strategy as outbreak grows
The trial could begin within two weeks if it receives regulatory and ethical approval, the Addis Ababa-based agency said in an email Sunday.
- ·
statnews.com
New study supports testing of Merck’s Ebola vaccine in DRC outbreak
New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another.
